17 Feb

Doctors on social media slam NICE diabetes guidance

Doctors are seemingly outraged by new draft guidelines on the treatment of diabetes published by...

Read more
14 Feb

Pharma is boosting pipelines to avoid patent cliff

Pharmaceutical companies have improved their pipelines of new drugs over the last 18 months...

Read more
11 Feb

Uruguay Marijuana Licenses Lure Bidders From Canada to Germany

(Bloomberg) -- Canadian medical-marijuana producer Tilray and the founder of a German cannabis...

Read more
26 Jan

AstraZeneca plc Lowered to “Underweight” at Barclays

Barclays lowered shares of AstraZeneca plc (LON:AZN) to an underweight rating in a research report...

Read more
23 Jan

Institute of Medicine Maps Out Clinical Trial Data Sharing Program

Investigators and sponsors of clinical trials will have to make more detailed data available...

Read more
21 Jan

Novel ‘Pay If You Clear’ scheme introduced in England for new hepatitis C treatment OLYSIO®

A new hepatitis C medicine, called simeprevir, is now available that the NHS in England will only...

Read more
19 Jan

Gilead to appeal India patent ruling on hepatitis C drug

U.S.-based Gilead Sciences Inc will appeal the Indian patent office's rejection of its application...

Read more
16 Jan

Why Now Is The Perfect Time To Buy GlaxoSmithKline plc

Life as a shareholder of GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) has not been particularly...

Read more
07 Nov

Cipla-Novartis patent row: DIPP looking into merit of case

Under Section 66 of IPA, Centre can revoke a patent in 'public interest' if it is of the opinion...

Read more
05 Nov

Dr Reddy's Laboratories may file new drug applications with FDA within year

HYDERABAD: Drug maker Dr Reddy's Laboratories has said it may file two new drug applications (NDA)...

Read more